-
28-06-2018, 09:31 PM
#751
Ok read it and it was pretty good read, lotta trees ;like that NZ Govt a customer coming too by the looks.
In terms of the unit sales performance for the 12 months to 31 March 2018, ArborGen sold 347 million seedlings globally, which was down slightly on the 351 million reported in the prior year, as the impact of the hurricane season took its toll on the growth we had otherwise planned to see in the US market. 270 million seedlings were sold in the US (236 million of which were loblolly pine), inclusive of more than 73 million in MCP and varietals, 19 million in Australasia, and 58 million in Brazil (50 million of which were eucalyptus). Most notably here, is that ArborGen’s advanced genetics sales in the US, as a percentage of its total loblolly pine sales, increased from 25% to 31%, with MCP sales up 22% on the prior year. This in turn saw the US loblolly pine ASP (average sale price) lift 7% year-on-year. Globally, loblolly and radiata advanced-genetics pine sales as a percentage of ArborGen’s total unit sales increased from 29% to 34%.
Last edited by Joshuatree; 28-06-2018 at 09:32 PM.
-
11-07-2018, 09:47 AM
#752
Long Member
https://www.nzx.com/announcements/320694
Kasnet gone, co-chairmen Knott and Tandon appointed.
-
11-07-2018, 10:09 AM
#753
Originally Posted by Well Endowed
The new director appointed - Ozey Horton- sound like just the man for the job as RBC moves toward realising its true value.
-
11-07-2018, 10:10 AM
#754
Originally Posted by Well Endowed
Well, both of them being the largest shareholders, hopefully can help the company realise its true potential. Let's wait and see...
-
11-07-2018, 10:23 AM
#755
Originally Posted by biker
The new director appointed - Ozey Horton- sound like just the man for the job as RBC moves toward realising its true value.
Yes an excellent appointment.
-
11-07-2018, 10:56 AM
#756
Another brick in the wall !
-
11-07-2018, 12:23 PM
#757
This is good news. Steven Knaset has finished his job selling Tenon, restructuring RBC and buying all of ArborGen. Well done and the right time to move on as the future requires totally different skill set.
Knott and Tandon own nearly half of RBC so are natural Chairmen for the co that should have shareholders interests at heart.
The new appointment Ozey is oozing the right experience for RBC
Positive announcement in my view
Last edited by iceman; 11-07-2018 at 01:10 PM.
-
18-07-2018, 10:04 AM
#758
The ducks continue to be lined up. Nice.
summa cum laude - "with highest honor". In North America, this honor is typically awarded to graduates in the top 1–5% of their class.
18/7/2018, 9:05 am GENERAL
18 July 2018 – Rubicon announced today that Mr Thomas Avery has been appointed to the Board as an Independent Director.
Tom has nearly 40 years of investment banking and venture capital experience. He has served on numerous private company boards throughout his career, advising companies on the successful financing, planning and execution of growth strategies. As an investment banker, Tom worked primarily with middle market growth companies in executing mergers and acquisitions, initial public offerings, and private placements of equity and debt. He served as a Managing Director at Raymond James & Associates from 2000-2014, which involved the management of the technology investment banking group and the financial sponsors’ efforts. Prior to that, Tom’s career saw him act as the head of the investment banking group at Interstate/Johnson-Lane, be a general partner at Summit Partners and at Noro-Moseley Partners, and work as a Senior Vice President at The Robinson-Humphrey Company. He currently has directorships at Cicero Inc., CRA International Inc, and KIPP Metro Atlanta.
Tom has a Bachelor of Science degree in Industrial Management, summa sum laude, from the Georgia Institute of Technology, and a Master’s in Business Administration from the Harvard Business School.
Rubicon’s Co-Chairmen, David Knott and Ranjan Tandon, welcomed Tom to the Board, saying “Tom’s extensive business experience with all aspects of the execution of growth strategies, particularly financing, will be put to good use as we increase the intensity of our focus on the continued commercialisation of ArborGen’s businesses in the United States, Brazil and Australasia. He will make a strong contribution towards Rubicon meeting and advancing its key milestones, and we are extremely pleased to have him with us as we move forward.”
Ends
Last edited by biker; 18-07-2018 at 10:14 AM.
-
18-07-2018, 10:08 AM
#759
Originally Posted by biker
The ducks continue to be lined up. Nice.
18/7/2018, 9:05 am GENERAL
18 July 2018 – Rubicon announced today that Mr Thomas Avery has been appointed to the Board as an Independent Director.
Tom has nearly 40 years of investment banking and venture capital experience. He has served on numerous private company boards throughout his career, advising companies on the successful financing, planning and execution of growth strategies. As an investment banker, Tom worked primarily with middle market growth companies in executing mergers and acquisitions, initial public offerings, and private placements of equity and debt. He served as a Managing Director at Raymond James & Associates from 2000-2014, which involved the management of the technology investment banking group and the financial sponsors’ efforts. Prior to that, Tom’s career saw him act as the head of the investment banking group at Interstate/Johnson-Lane, be a general partner at Summit Partners and at Noro-Moseley Partners, and work as a Senior Vice President at The Robinson-Humphrey Company. He currently has directorships at Cicero Inc., CRA International Inc, and KIPP Metro Atlanta.
Tom has a Bachelor of Science degree in Industrial Management, summa sum laude, from the Georgia Institute of Technology, and a Master’s in Business Administration from the Harvard Business School.
Rubicon’s Co-Chairmen, David Knott and Ranjan Tandon, welcomed Tom to the Board, saying “Tom’s extensive business experience with all aspects of the execution of growth strategies, particularly financing, will be put to good use as we increase the intensity of our focus on the continued commercialisation of ArborGen’s businesses in the United States, Brazil and Australasia. He will make a strong contribution towards Rubicon meeting and advancing its key milestones, and we are extremely pleased to have him with us as we move forward.”
Ends
Another block in the wall today, Im picking that a rerating will be applied shortly with these company building anns, could be the winning share of 2019 !
-
18-07-2018, 10:12 AM
#760
Originally Posted by whatsup
Another block in the wall today, Im picking that a rerating will be applied shortly with these company building anns, could be the winning share of 2019 !
Couldn't agree more...slowly realising its potential. Price getting close to NTA of 40c is the first target.
Tags for this Thread
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
|
|
Bookmarks